Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,274 | 57 | 98.6% |
| Debt forgiveness | $17.50 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $271.73 | 8 | $0 (2024) |
| ABBVIE INC. | $149.64 | 10 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $148.24 | 2 | $0 (2024) |
| Lilly USA, LLC | $110.76 | 5 | $0 (2024) |
| Novo Nordisk Inc | $74.82 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $51.92 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $44.26 | 3 | $0 (2022) |
| Amgen Inc. | $41.72 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $41.66 | 2 | $0 (2024) |
| PFIZER INC. | $37.76 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $638.31 | 30 | Phathom Pharmaceuticals, Inc. ($148.24) |
| 2023 | $561.38 | 22 | AstraZeneca Pharmaceuticals LP ($242.56) |
| 2022 | $92.09 | 6 | Teva Pharmaceuticals USA, Inc. ($44.26) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), PEAK, MONOVISC | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Sports Early Intervention | ||||||
| 09/25/2024 | Mirum Pharmaceuticals, Inc. | Cholbam (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Hepatology | ||||||
| 08/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Biological | ||||||
| 07/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Biological | ||||||
| 06/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Inflammation | ||||||
| 06/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 05/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 251 | 1,432 | $96,431 | $27,763 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 28 | 164 | $37,857 | $5,564 | 14.7% |
| 97112 | Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2021 | 22 | 250 | $14,140 | $5,272 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 75 | $9,594 | $4,704 | 49.0% |
| 97110 | Therapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2021 | 26 | 209 | $8,565 | $3,666 | 42.8% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2021 | 49 | 405 | $8,215 | $3,049 | 37.1% |
| 97140 | Manual (physical) therapy techniques to 1 or more regions, each 15 minutes | Office | 2021 | 24 | 96 | $4,025 | $1,489 | 37.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $5,700 | $1,397 | 24.5% |
| 97012 | Application of mechanical traction to 1 or more areas | Office | 2021 | 21 | 166 | $6,175 | $1,364 | 22.1% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2021 | 24 | 48 | $2,160 | $1,258 | 58.2% |
About Michael Babinski, NP
Michael Babinski, NP is a Adult Health healthcare provider based in Highland, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/31/2020. The National Provider Identifier (NPI) number assigned to this provider is 1699362020.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Babinski, NP has received a total of $1,292 in payments from pharmaceutical and medical device companies, with $638.31 received in 2024. These payments were reported across 58 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,274).
As a Medicare-enrolled provider, Babinski has provided services to 251 Medicare beneficiaries, totaling 1,432 services with total Medicare billing of $27,763. Data is available for 1 year (2021–2021), covering 9 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Highland, IL
- Active Since 12/31/2020
- Last Updated 01/10/2024
- Taxonomy Code 363LA2200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699362020
Products in Payments
- FARXIGA (Drug) $151.52
- VOQUEZNA (Drug) $148.24
- BREZTRI (Drug) $106.39
- MOUNJARO (Drug) $95.04
- VRAYLAR (Drug) $92.24
- REXULTI (Drug) $70.48
- Otezla (Drug) $41.72
- Veozah (Drug) $41.66
- QULIPTA (Drug) $39.56
- JARDIANCE (Drug) $36.58
- MOVANTIK (Drug) $34.99
- Ozempic (Drug) $32.00
- LEQVIO (Drug) $29.74
- Rybelsus (Drug) $28.55
- ORTHOVISC (Device) $24.46
- SPRAVATO (Drug) $24.41
- Cholbam (Drug) $24.40
- NURTEC ODT (Drug) $22.20
- Adzenys XR-ODT (Drug) $21.92
- Kerendia (Drug) $20.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Highland
Erika Schulze, Np, NP
Adult Health — Payments: $205.45
Joshua Sandifer, Agpcnp-Bc, AGPCNP-BC
Adult Health — Payments: $114.30
Ms. Judith Perrotte, Np, NP
Adult Health — Payments: $20.36
Ms. Ann Johnson, Anp, ANP
Adult Health
Mrs. Lauren Wienczak, Anp-Bc, ANP-BC
Adult Health